Cytotoxicity of 5-fluorouracil entrapped in gelatin microspheres

References

• AKIN, H. and HASIRCI, N., 1995, Preparation and characterization of crosslinked gelatin microspheres. Journal of Applied Polymer Science, 58, 95–100.
   Web of Science ®Google Scholar
• BALL, D. S., HECKMAN, R., OLENICK, S. W., FOLANDER, H. L. and REED, J., III, 2003, In vitro stability of tris-acryl gelatin microspheres in a multipharmaceutical chemoembolization solution. Journal of Vascular and Interval Radiology, 14, 83–88.
   PubMed Web of Science ®Google Scholar
• CHASIN, M. and LANGER, R., 1990, Biodegradable Polymers as Drug Delivery Systems (New York: Marcel Dekker).
   Google Scholar
• CHOWDHURY, D. K. and MITRA, A. K., 1999, Kinetics of in vitro release of a model nucleoside deoxyuridine from crosslinked insoluble collagen and collagen—gelatin microspheres. International Journal of Pharmaceutics, 193, 113–122.
   PubMed Web of Science ®Google Scholar
• DAMINK, O. L. H. H., DIJKSTRA, P. J., VAN LUYN, M. J. A., WACHEM, P. B., NIEUWENHUIS, P. and FEIJEN, J., 1995, Glutaraldehyde as a crosslinking agent for collagen based biomaterials. Journal of Materials Science: Materials in Medicine, 6, 460–472.
   Google Scholar
• DIASIO, R. B. and HARRIS, B. E., 1989, Clinical pharmacology of 5-fluorouracil. Clinical Pharmacokinetics, 16, 215–237.
   PubMed Web of Science ®Google Scholar
• FORNI, F., VANDELLI, M. A. and CAMERONI, R., 1992, Influence of drug loading level on drug release and dynamic swelling of crosslinked gelatin microspheres. Journal of Microencapsulation, 9, 29–39.
   PubMed Web of Science ®Google Scholar
• FRESHNEY, I., 1994, Culture of Animal Cells (New York: Wiley-Liss).
   Google Scholar
• GOLDBERG, J. A., WILLMOTT, N. S., ANDERSON, J. H., MCCURRACH, G., BESSENT, R. G., McKILLoP, J. H. and MCARDLE, C. S., 1991, The biodegradation of albumin microspheres used for regional chemotherapy in patients with colorectal liver metastases. Nuclear Medicine Communications, 12, 57–63.
   PubMed Web of Science ®Google Scholar
• HANES, J., SILLS, A., ZHAO, Z., SUH, K. W., TYLER, B., DIMECO, F., BRAT, D. J., CHOTI, M. A., LEONG, K. W., PARDOLL, D. M. and BREM, H., 2001, Controlled local delivery of interleukin-2 by biodegradable polymers protects animals from experimental brain tumors and liver tumors. Pharmacology Research, 18, 899–906.
   PubMed Web of Science ®Google Scholar
• JAYAKRISHNAN, A. and JAMEELA, S. R., 1996, Glutaraldehyde as a fixative in bioprosthesis and drug delivery matrices. Biomaterials, 17, 471–484.
   PubMed Web of Science ®Google Scholar
• JEYANTTHI, R. and RAO, K. P., 1989, Release characteristics of bleomycin, mitomycin c and 5-fluorouracil from gelatin microspheres. International Journal of Pharmaceutics, 55, 31–37.
   Web of Science ®Google Scholar
• KUANG, L., YANG, D. J., INouE, T., Liu, W. C., WALLACE, S. and WRIGHT, K. C., 1996, Percutaneous intratumoral injection of cisplatin microspheres in tumor bearing rats to diminish acute nephrotoxicity. Anticancer Drugs, 7, 220–227.
   PubMed Web of Science ®Google Scholar
• LANGER, R., 1985, Biomaterials: new perspectives on their use in the controlled delivery of polypeptides. Pharmaceutical Technology, 10, 35–40.
   Google Scholar
• LANGER, R., 1990, New methods of drug delivery. Science, 249, 1527.
   PubMed Web of Science ®Google Scholar
• LANGER, R. S. and PEPPAS, N. A., 1981, Present and future applications of biomaterials in controlled delivery systems. Biomaterials, 2, 201–214.
   PubMed Web of Science ®Google Scholar
• LOPEZ, J. M., IMPERIAL, S., VALDERRAMA, R. and NAVARRO, S., 1993, An improved Bradford protein assay for collagen proteins. Clinica et Chimica Acta, 220, 91–100.
   PubMed Web of Science ®Google Scholar
• MUVAFFAK, A., 2003, Controlled release systems for anticancer drugs and drug targeting in cancer therapy. PhD thesis, Middle East Technical University, Ankara. MUVAFFAK, A. and HASIRCI, N., 2002, Controlled release from glutaraldehyde crosslinked gelatin microspheres. Technology and Health Care, 10, 347–350.
   Google Scholar
• NAKASE, H., OKAZAKI, K., TABATA, Y., OZEKI, M., WATANABE, N., OHANA, M., UOSE, S., UCHIDA, K., NISHI, T., MASTUURA, M., TAMAKI, H., 'Toff, T., KAWANAMI, C. and CHIBA, T., 2002, New cytokine delivery system using gelatin microspheres containing interleukin-10 for experimental inflammatory bowel disease. Journal of Pharmacology and Experimental Therapeutics, 301, 59–65.
   Google Scholar
• NARAYANI, R. and RAO, K. P., 1994, Controlled release of the anticancer drug metho-trexate from biodegradable gelatin microspheres. Journal of Microencapsulation, 11, 69–77.
   PubMed Web of Science ®Google Scholar
• NARAYANI, R. and RAO, K. P., 1995, pH responsive gelatin microspheres for the oral delivery of anticancer drug metrotrexate. Journal of Applied Polymer Science, 58, 1761–1769.
   Web of Science ®Google Scholar
• NARAYANI, R. and RAO, K. P., 1996, Biodegradable microspheres using two different gelatin drug conjugates for the controlled delivery of methotrexate. International Journal of Pharmaceutics, 128, 261–268.
   Web of Science ®Google Scholar
• OKADA, H. and TOGUCHI, H., 1995, Biodegradable microspheres in drug delivery. Critical Reviews in Therapeutic Drug Carrier Systems, 12, 1–99.
   PubMed Web of Science ®Google Scholar
• PRABHU, S., SULLIVAN, J. L. and BETAGERI, G. V., 2002, Comparative assessment of in vitro release kinetics of calcitonin polypeptide from biodegradable microspheres. Drug Delivery, 9, 195–198.
   PubMed Web of Science ®Google Scholar
• ROUTLEDGE, E. D., GORMAN, S. and CLARK, M. R., 1994, Cell and Tissue Culture: Laboratory Procedures (New York: Wiley).
   Google Scholar
• RUMP, A. F., WOSCHEE, U., THEISOHN, M., FISCHBACH, R., HEINDEL, W., LACKNER, K. and KLAUS, W., 2002, Pharmacokinetics of intra-arterial mitomycin C in the chemoembolization treatment of liver metastases with polyvinylalcohol or degradable starch microspheres. European Journal of Clinical Pharmacology, 58, 459–465.
   PubMed Web of Science ®Google Scholar
• TEDER, H., JOHANSSON, C. J., D'ARGY, R., LUNDIN, N. and GUNNARSSON, P. O, 1995, The effect of different dose levels of degradable starch microspheres (Spherex) on the distribution of a cytotoxic drug after regional administration to tumour-bearing rats. European Journal of Cancer, 31A, 1701–1705.
   Google Scholar
• TERWOGT, J. M. M., SCHELLENS, J. H. M., TEN, W. W., HUININK, B. and BEIJNEN, J. H., 1999, Clinical pharmacology of anticancer agents in relation to formulations and administration routes. Cancer Treatment Reviews, 25, 83–101.
   Google Scholar
• VANDELLI, M. A., RIVASI, F., GUERRA, P., FORNI, F. and ARLETTI, R., 2001, Gelatin microspheres crosslinked with D,L-glyceraldehyde as a potential drug delivery system: preparation, characterization, in vitro and in vivo studies. International Journal of Pharmaceutics, 215, 175–184.
   PubMed Web of Science ®Google Scholar
• YAN, R. C., LI, X., CHEN, X., WANG, D., ZHONG, D., TAN, T. and KITANO, H., 1991, Anticancer gelatin microspheres with multiple functions. Biomaterials, 12, 640–644.
   PubMed Web of Science ®Google Scholar
• YOSHIKAWA, Y., KOMUTA, Y., NISHIHARA, T., ProH, Y., YOSHIKAWA, H. and TAKADA, K., 1999, Preparation and evaluation of once-a-day injectable microspheres of interferon alpha in rats. Journal of Drug Targeting, 6, 449–461.
   PubMed Web of Science ®Google Scholar